Adalta Ltd has released a press release.
AdCella milestones and regulatory progress
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from AdAlta
- Placement raises A$1.2 million
- CAR-T collaboration agreement
- $0.78 million FY25 RDTI refund received
- AGM share consolidation resolution withdrawal
- Meurs Group Investment Agreement Update
Later from AdAlta
- Quarterly Appendix 4C and Activities Report
- Half Yearly Report and Accounts
- AdCella Clinical Advisory Board convened
- AdCella expands clinical advisory board
- New AD-214 patent granted
Follow AdAlta into a list and get an email when it puts out news.
Follow AdAlta